Marshall Wace’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,115,744
| Closed | -$2.9M | – | 3618 |
|
|
2025
Q4 | $2.9M | Buy |
+1,115,744
| New | +$2.25M | ﹤0.01% | 1403 |
|
|
2025
Q1 | – | Sell |
-46,876
| Closed | -$61.4K | – | 3027 |
|
|
2024
Q4 | $61.4K | Sell |
46,876
-72,232
| -61% | -$215K | ﹤0.01% | 2478 |
|
|
2024
Q3 | $410K | Buy |
119,108
+36,518
| +44% | +$120K | ﹤0.01% | 1994 |
|
|
2024
Q2 | $273K | Buy |
+82,590
| New | +$295K | ﹤0.01% | 2191 |
|
|
2024
Q1 | – | Sell |
-26,866
| Closed | -$196K | – | 2757 |
|
|
2023
Q4 | $196K | Buy |
+26,866
| New | +$150K | ﹤0.01% | 1983 |
|
|
2023
Q1 | – | Sell |
-39,489
| Closed | -$581K | – | 3049 |
|
|
2022
Q4 | $581K | Buy |
+39,489
| New | +$591K | ﹤0.01% | 2316 |
|
|
2022
Q3 | – | Sell |
-30,900
| Closed | -$433K | – | 3732 |
|
|
2022
Q2 | $433K | Buy |
+30,900
| New | +$364K | ﹤0.01% | 2862 |
|
Marshall Wace's RPTX Position: Q1 2026 in Review
Marshall Wace sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 1,115,744 shares — an estimated $2.9M sold.
Marshall Wace first reported a position in RPTX in Q2 2022 and held it in 7 quarters. The position peaked at $2.9M in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.
- Marshall Wace reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
- Marshall Wace sold 1,115,744 Repare Therapeutics shares in Q1 2026, an estimated $2.9M.
- Marshall Wace first reported a position in Repare Therapeutics in Q2 2022 and held it in 7 quarters.
- Marshall Wace's Repare Therapeutics position peaked at $2.9M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.